<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10075645" created="11/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10075645</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Bacterial <term id="T1" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> activates <term id="T2" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> through <term id="T3" lex="interleukin-1_signaling_mediator" sem="Protein_family_or_group">interleukin-1 signaling mediators</term> in <term id="T4" lex="cultured_human_dermal_endothelial_cell" sem="Cell_cultured">cultured human dermal endothelial cells</term> and <term id="T5" lex="mononuclear_phagocyte" sem="Cell_natural">mononuclear phagocytes</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T3"/>
<cause idref="T1"/>
<clue>Bacterial lipopolysaccharide <clueType>activates</clueType> nuclear factor-kappaB <linkTheme>through</linkTheme> interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="E1"/>
<clue>Bacterial lipopolysaccharide <clueType>activates</clueType> nuclear factor-kappaB <linkCause>through</linkCause> interleukin-1 signaling mediators <clueLoc>in cultured human dermal endothelial cells</clueLoc> and mononuclear phagocytes.</clue>
</event>
<event id="E102">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="E1"/>
<clue>Bacterial lipopolysaccharide <clueType>activates</clueType> nuclear factor-kappaB <linkCause>through</linkCause> interleukin-1 signaling mediators <clueLoc>in cultured human</clueLoc> dermal endothelial cells and <clueLoc>mononuclear phagocytes</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Bacterial <term id="T7" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T71" sem="Lipid">LPS</term>)-mediated <term id="A1" sem="Other">immune responses</term>, including activation of <term id="T8" lex="monocyte" sem="Cell_natural">monocytes</term>, <term id="T9" lex="macrophage" sem="Cell_natural">macrophages</term>, and <term id="T10" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term>, play an important role in the pathogenesis of <term id="T12" lex="Gram-negative_bacteria" sem="Unicellular_organism">Gram-negative bacteria</term>-induced <term id="A2" sem="Other">sepsis syndrome</term>.</sentence>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="T7"/>
<clue>Bacterial lipopolysaccharide (LPS)-<clueType>mediated</clueType> immune responses, including activation of monocytes, macrophages, and endothelial cells, play an important role in the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Other" id="E4">
<type class="Physiological_process"/>
<theme idref="T8"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including <clueType>activation</clueType> <linkTheme>of</linkTheme> monocytes, macrophages, and endothelial cells, play an important role in the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="T9"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including <clueType>activation</clueType> <linkTheme>of</linkTheme> monocytes, macrophages, and endothelial cells, play an important role in the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Other" id="E6">
<type class="Physiological_process"/>
<theme idref="T10"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including <clueType>activation</clueType> <linkTheme>of</linkTheme> monocytes, macrophages, and endothelial cells, play an important role in the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T12"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including activation of monocytes, macrophages, and endothelial cells, play an important role in the pathogenesis of Gram-negative bacteria-<clueType>induced</clueType> sepsis syndrome.</clue>
</event>
<event KT="Other" id="E8">
<type/>
<theme idref="E7"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including activation of monocytes, macrophages, and endothelial cells, play an important role in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> Gram-negative bacteria-induced sepsis syndrome.</clue>
<comment>SOO</comment></event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E3"/>
<clue>Bacterial lipopolysaccharide (LPS)-mediated immune responses, including activation of monocytes, macrophages, and endothelial cells, <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E4"/>
<clue><corefCause>Bacterial lipopolysaccharide (LPS)-mediated immune responses</corefCause>, including activation of monocytes, macrophages, and endothelial cells, <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E5"/>
<clue><corefCause>Bacterial lipopolysaccharide (LPS)-mediated immune responses</corefCause>, including activation of monocytes, macrophages, and endothelial cells, <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E6"/>
<clue><corefCause>Bacterial lipopolysaccharide (LPS)-mediated immune responses</corefCause>, including activation of monocytes, macrophages, and endothelial cells, <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of Gram-negative bacteria-induced sepsis syndrome.</clue>
</event>
<sentence id="S3"><term id="T52" sem="Other">Activation</term> of <term id="T13" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> is thought to be required for <term id="T72" sem="Other"><term id="A3" sem="Protein_family_or_group">cytokine</term> release</term> from <term id="T14" lex="LPS-responsive_cell" sem="Cell_natural"><term id="T46" sem="Lipid">LPS</term>-responsive cells</term>, a critical step for <term id="T15" lex="endotoxic_effects" sem="Other">endotoxic effects</term>.</sentence>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> NF-kappaB is thought to be required for cytokine release from LPS-responsive cells, a critical step for endotoxic effects.</clue>
</event>
<event KT="Other" id="E14">
<type class="Localization"/>
<theme idref="A3"/>
<clue>Activation of NF-kappaB is thought to be required for cytokine <clueType>release</clueType> <clueLoc>from LPS-responsive cells</clueLoc>, a critical step for endotoxic effects.</clue>
</event>
<event KT="Fact" id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="E13"/>
<clue>Activation of NF-kappaB is <clueKT>thought</clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> cytokine release from LPS-responsive cells, a critical step for endotoxic effects.</clue>
</event>
<sentence id="S4">Here we investigated the role and <term id="T73" sem="Other">involvement</term> of <term id="T16" lex="interleukin-1" sem="Protein_molecule">interleukin-1</term> (<term id="T17" lex="IL-1" sem="Protein_molecule">IL-1</term>) and <term id="T18" lex="tumor_necrosis_factor" sem="Protein_family_or_group">tumor necrosis factor</term> (<term id="T19" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>) <term id="T20" lex="signal_transducer_molecule" sem="Protein_family_or_group">signal transducer molecules</term> in <term id="T21" lex="LPS_signaling" sem="Other"><term id="T22" lex="LPS" sem="Lipid">LPS</term> signaling</term> in <term id="T23" lex="human_dermal_microvessel_endothelial_cell" sem="Cell_natural">human dermal microvessel endothelial cells</term> (<term id="T25" lex="HDMEC" sem="Cell_natural">HDMEC</term>) and <term id="T26" lex="THP-1_monocytic_cell" sem="Cell_natural">THP-1 monocytic cells</term>.</sentence>
<event KT="Other" id="E16">
<type class="Cell_communication"/>
<theme idref="T22"/>
<clue>Here we investigated the role and involvement of interleukin-1 (IL-1) and tumor necrosis factor (TNF-alpha) signal transducer molecules in LPS <clueType>signaling</clueType> in human dermal microvessel endothelial cells (HDMEC) and THP-1 monocytic cells.</clue>
</event>
<event KT="Investigation" id="E17" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T17"/>
<theme idref="T22"/>
<clue>Here we <clueKT>investigated</clueKT> the <clueType>role and involvement</clueType> <linkCause>of</linkCause> interleukin-1 (IL-1) and tumor necrosis factor (TNF-alpha) signal transducer molecules <linkTheme>in</linkTheme> LPS signaling <clueLoc>in human dermal microvessel endothelial cells (HDMEC)</clueLoc> and THP-1 monocytic cells.</clue>
</event>
<event KT="Investigation" id="E117" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T17"/>
<theme idref="T22"/>
<clue>Here we <clueKT>investigated</clueKT> the <clueType>role and involvement</clueType> <linkCause>of</linkCause> interleukin-1 (IL-1) and tumor necrosis factor (TNF-alpha) signal transducer molecules <linkTheme>in</linkTheme> LPS signaling <clueLoc>in</clueLoc> human dermal microvessel endothelial cells (HDMEC) and <clueLoc>THP-1 monocytic cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E18" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T19"/>
<theme idref="T22"/>
<clue>Here we <clueKT>investigated</clueKT> the <clueType>role and involvement</clueType> <linkCause>of</linkCause> interleukin-1 (IL-1) and tumor necrosis factor (TNF-alpha) signal transducer molecules <linkTheme>in</linkTheme> LPS signaling <clueLoc>in human dermal microvessel endothelial cells (HDMEC)</clueLoc> and THP-1 monocytic cells.</clue>
</event>
<event KT="Investigation" id="E118" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T19"/>
<theme idref="T22"/>
<clue>Here we <clueKT>investigated</clueKT> the <clueType>role and involvement</clueType> <linkCause>of</linkCause> interleukin-1 (IL-1) and tumor necrosis factor (TNF-alpha) signal transducer molecules <linkTheme>in</linkTheme> LPS signaling <clueLoc>in</clueLoc> human dermal microvessel endothelial cells (HDMEC) and <clueLoc>THP-1 monocytic cells</clueLoc>.</clue>
</event>
<sentence id="S5"><term id="T24" sem="Other"><term id="T27" lex="LPS" sem="Lipid">LPS</term> stimulation</term> of <term id="T28" lex="HDMEC" sem="Cell_natural">HDMEC</term> and <term id="T29" lex="THP-1_cell" sem="Cell_cultured">THP-1 cells</term> initiated an <term id="T31" lex="IL-1_receptor" sem="Protein_family_or_group"><term id="T32" lex="IL-1" sem="Protein_molecule">IL-1</term> receptor</term>-like <term id="T6" sem="Other"><term id="T33" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> signaling cascade</term>.</sentence>
<event id="E19">
<type class="Physiological_process"/>
<theme idref="T28"/>
<cause idref="T27"/>
<clue>LPS <clueType>stimulation</clueType> <linkTheme>of</linkTheme> HDMEC and THP-1 cells initiated an IL-1 receptor-like NF-kappaB signaling cascade.</clue>
</event>
<event id="E20">
<type class="Physiological_process"/>
<theme idref="T29"/>
<cause idref="T27"/>
<clue>LPS <clueType>stimulation</clueType> <linkTheme>of</linkTheme> HDMEC and THP-1 cells initiated an IL-1 receptor-like NF-kappaB signaling cascade.</clue>
</event>
<event id="E43">
<type class="Cell_communication"/>
<theme idref="T33"/>
<clue>LPS stimulation of HDMEC and THP-1 cells initiated an IL-1 receptor-like NF-kappaB <clueType>signaling</clueType> cascade.</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E19"/>
<clue>LPS stimulation of HDMEC and THP-1 cells <clueType>initiated</clueType> an IL-1 receptor-like NF-kappaB signaling cascade.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E20"/>
<clue>LPS stimulation of HDMEC and THP-1 cells <clueType>initiated</clueType> an IL-1 receptor-like NF-kappaB signaling cascade.</clue>
</event>
<sentence id="S6">In <term id="T34" sem="Other">transient cotransfection experiments</term>, <term id="T74" sem="Cell_cultured">dominant negative mutants</term> of the <term id="T35" lex="IL-1_signaling_pathway" sem="Other"><term id="T36" lex="IL-1" sem="Protein_molecule">IL-1</term> signaling pathway</term>, including <term id="T37" lex="MyD88" sem="Protein_molecule">MyD88</term>, <term id="T38" lex="IRAK" sem="Protein_molecule">IRAK</term>, <term id="T39" lex="IRAK2" sem="Protein_molecule">IRAK2</term>, and <term id="T40" lex="TRAF6" sem="Protein_molecule">TRAF6</term> inhibited both <cons id="C1" lex="(AND IL-1-induced_NF-kappaB-luciferase_activity LPS-induced_NF-kappaB-luciferase_activity)" sem="(AND Other Other)"><frag id="F1">IL-1</frag><frag id="F2">-</frag> and <frag id="F3">LPS</frag><frag id="F4">-</frag><frag id="F5">induced</frag> <frag id="F6">NF-kappaB-luciferase</frag> <frag id="F7">activity</frag></cons>.</sentence>
<event id="E44">
<type class="Mutagenesis"/>
<theme idref="T37"/>
<clue>In transient cotransfection experiments, dominant negative <clueType>mutants</clueType> <linkTheme>of</linkTheme> the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E45">
<type class="Mutagenesis"/>
<theme idref="T38"/>
<clue>In transient cotransfection experiments, dominant negative <clueType>mutants</clueType> <linkTheme>of</linkTheme> the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E46">
<type class="Mutagenesis"/>
<theme idref="T39"/>
<clue>In transient cotransfection experiments, dominant negative <clueType>mutants</clueType> <linkTheme>of</linkTheme> the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E47">
<type class="Mutagenesis"/>
<theme idref="T40"/>
<clue>In transient cotransfection experiments, dominant negative <clueType>mutants</clueType> <linkTheme>of</linkTheme> the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="F6"/>
<cause idref="F1"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-<clueType>induced</clueType> NF-kappaB-luciferase activity.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="F6"/>
<cause idref="F3"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 inhibited both IL-1- and LPS-<clueType>induced</clueType> NF-kappaB-luciferase activity.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E44"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E44"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E45"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E45"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E46"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E46"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E47"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E47"/>
<clue>In transient cotransfection experiments, dominant negative mutants of the IL-1 signaling pathway, including MyD88, IRAK, IRAK2, and TRAF6 <clueType>inhibited</clueType> both IL-1- and LPS-induced NF-kappaB-luciferase activity.</clue>
</event>
<sentence id="S7"><term id="T47" lex="LPS" sem="Lipid">LPS</term>-induced <term id="T30" sem="Other"><term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> was not inhibited by a dominant negative mutant of <term id="T49" lex="TRAF2" sem="Protein_molecule">TRAF2</term> that is involved in <term id="T50" lex="TNF_signaling" sem="Other"><term id="T51" lex="TNF" sem="Protein_family_or_group">TNF</term> signaling</term>.</sentence>
<event id="E48">
<type class="Mutagenesis"/>
<theme idref="T49"/>
<clue>LPS-induced NF-kappaB activation was not inhibited by a dominant <clueType>negative mutant</clueType> of TRAF2 that is involved in TNF signaling.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<clue>LPS-induced NF-kappaB <clueType>activation</clueType> was not inhibited by a dominant negative mutant of TRAF2 that is involved in TNF signaling.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<cause idref="T47"/>
<clue>LPS-<clueType>induced</clueType> NF-kappaB activation was not inhibited by a dominant negative mutant of TRAF2 that is involved in TNF signaling.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E35">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="E48"/>
<clue>LPS-induced NF-kappaB activation was <cluePolarity>not</cluePolarity> <clueType>inhibited</clueType> <linkCause>by</linkCause> a dominant negative mutant of TRAF2 that is involved in TNF signaling.</clue>
</event>
<event KT="Other" id="E36">
<type class="Cell_communication"/>
<theme idref="T51"/>
<clue>LPS-induced NF-kappaB activation was not inhibited by a dominant negative mutant of TRAF2 that is involved in TNF <clueType>signaling</clueType>.</clue>
</event>
<event KT="Fact" id="E37">
<type class="Correlation"/>
<theme idref="T49"/>
<theme idref="E36"/>
<clue>LPS-induced NF-kappaB activation was not inhibited by a dominant negative mutant of TRAF2 that is <clueType>involved</clueType> <linkTheme>in</linkTheme> TNF signaling.</clue>
</event>
<sentence id="S8"><term id="T53" lex="LPS" sem="Lipid">LPS</term>-induced <term id="T45" sem="Other">activation</term> of <term id="T54" lex="NF-kappaB-responsive_reporter_gene" sem="DNA_domain_or_region"><term id="T55" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-responsive reporter gene</term> was not inhibited by <term id="T56" lex="IL-1_receptor_antagonist" sem="Other"><term id="T57" lex="IL-1" sem="Protein_molecule">IL-1 receptor</term> antagonist</term>.</sentence>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="T55"/>
<clue>LPS-induced <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappaB-responsive reporter gene was not inhibited by IL-1 receptor antagonist.</clue>
<comment>NER T57 mod</comment></event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T53"/>
<clue>LPS-<clueType>induced</clueType> activation of NF-kappaB-responsive reporter gene was not inhibited by IL-1 receptor antagonist.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T56"/>
<clue>LPS-induced activation of NF-kappaB-responsive reporter gene was <cluePolarity>not</cluePolarity> <clueType>inhibited</clueType> <linkCause>by</linkCause> IL-1 receptor antagonist.</clue>
</event>
<sentence id="S9"><term id="T58" lex="TLR2" sem="Protein_molecule">TLR2</term> and <term id="T59" lex="TLR4" sem="Protein_molecule">TLR4</term> were expressed on the cell surface of <term id="T60" lex="HDMEC" sem="Cell_natural">HDMEC</term> and <term id="T61" lex="THP-1_cell" sem="Cell_cultured">THP-1 cells</term>.</sentence>
<event id="E41">
<type class="Gene_expression"/>
<theme idref="T58"/>
<clue>TLR2 and TLR4 were <clueType>expressed</clueType> <clueLoc>on the cell surface of HDMEC</clueLoc> and THP-1 <clueLoc>cells</clueLoc>.</clue>
</event>
<event id="E141">
<type class="Gene_expression"/>
<theme idref="T58"/>
<clue>TLR2 and TLR4 were <clueType>expressed</clueType> <clueLoc>on the cell surface of</clueLoc> HDMEC and <clueLoc>THP-1 cells</clueLoc>.</clue>
</event>
<event id="E42">
<type class="Gene_expression"/>
<theme idref="T59"/>
<clue>TLR2 and TLR4 were <clueType>expressed</clueType> <clueLoc>on the cell surface of HDMEC</clueLoc> and THP-1 cells.</clue>
</event>
<event id="E142">
<type class="Gene_expression"/>
<theme idref="T59"/>
<clue>TLR2 and TLR4 were <clueType>expressed</clueType> <clueLoc>on the cell surface of</clueLoc> HDMEC and <clueLoc>THP-1 cells</clueLoc>.</clue>
</event>
<sentence id="S10">These findings suggest that a <term id="T62" lex="signal_transduction_molecule" sem="Protein_family_or_group">signal transduction molecule</term> in the <term id="A6" sem="Protein_complex"><term id="T63" lex="LPS" sem="Lipid">LPS</term> receptor complex</term> may belong to the <term id="A7" sem="Protein_family_or_group"><term id="T64" lex="IL-1" sem="Protein_molecule">IL-1</term> receptor/toll-like receptor (TLR) super family</term>, and the <term id="T65" lex="LPS_signaling" sem="Other"><term id="T66" lex="LPS" sem="Lipid">LPS</term> signaling</term> cascade uses an <term id="T67" lex="analogous_molecular_framework" sem="Other">analogous molecular framework</term> for signaling as <term id="T68" lex="IL-1" sem="Protein_molecule">IL-1</term> in <term id="T69" lex="mononuclear_phagocyte" sem="Cell_natural">mononuclear phagocytes</term> and <term id="T70" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
